Covid19
Showing NaN - NaN of 18
Covid19 Trial in Birmingham (Alvelestat, Placebo)
COVID19, Coronavirus, Acute Respiratory Illnesses Trial in Worldwide (Chloroquine or Hydroxychloroquine, Placebo)
Completed
- COVID19
- +2 more
- Chloroquine or Hydroxychloroquine
- Placebo
-
Abomey-Calavi, Benin
- +24 more
Jan 10, 2023
SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination
Active, not recruiting
- SARS-CoV Infection
- Covid19
- SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
- +5 more
-
Birmingham, Alabama
- +155 more
Dec 16, 2022
High Resolution Micro OCT Imaging
Recruiting
- Cystic Fibrosis
- +4 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 13, 2022
Asymptomatic SARS-CoV-2 Detection in Children
Completed
- Covid19
- SARS-CoV-2
-
Birmingham, Alabama
- +4 more
Nov 1, 2022
Respiratory Failure, Covid19 Trial in Birmingham (Mask with Mask Adhesive/Arm 1, Mask without Mask Adhesive / Arm 2)
Terminated
- Respiratory Failure
- Covid19
- Mask with Mask Adhesive/Arm 1
- Mask without Mask Adhesive / Arm 2
-
Birmingham, AlabamaSleep Disorder Center of Alabama
Jul 25, 2022
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
Acute Respiratory Distress Syndrome, Covid19 Trial in United States (Descartes 30)
Recruiting
- Acute Respiratory Distress Syndrome
- Covid19
- Descartes 30
-
Birmingham, Alabama
- +5 more
May 19, 2022
COVID-19 Associated Pulmonary Aspergillosis and Other Invasive
Recruiting
- Covid19
- +2 more
- Observation to monitor patients for these infections
-
Birmingham, AlabamaThe University of Alabama at Birmingham
Apr 21, 2022
ARDS, Covid19, Acute Hypoxemic Respiratory Failure Trial in Birmingham (Prolonged Proned Positioning, Traditional Proning Arm)
Completed
- ARDS
- +2 more
- Prolonged Proned Positioning
- Traditional Proning Arm
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Mar 29, 2022
Covid19 Trial in United Kingdom (Niclosamide, Placebo, Ciclesonide)
Recruiting
- Covid19
- Niclosamide
- +3 more
-
Cambridge, Cambridgeshire, United Kingdom
- +34 more
Feb 20, 2022
COVID-19 Antibody Responses In Cystic Fibrosis
Recruiting
- Covid19
- Cystic Fibrosis
-
Southampton, Engladn, United Kingdom
- +10 more
Jan 17, 2022
COVID19 Trial in Birmingham (Tranexamic acid, Placebo oral tablet)
Withdrawn
- COVID19
- Tranexamic acid
- Placebo oral tablet
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Apr 21, 2021
Acute and Chronic Kidney Disease Incidence and Outcomes in
Enrolling by invitation
- Covid19
- +4 more
-
Birmingham, Alabama
- +11 more
Jul 27, 2020